| Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity X Qi, F Li, Y Wu, C Cheng, P Han, J Wang, X Yang Nature communications 10 (1), 2141, 2019 | 120 | 2019 |
| Spinal IL-33/ST2 Signaling Contributes to Neuropathic Pain via Neuronal CaMKII–CREB and Astroglial JAK2–STAT3 Cascades in Mice S Liu, WL Mi, Q Li, MT Zhang, P Han, S Hu, QL Mao-Ying, YQ Wang Anesthesiology 123 (5), 1154-1169, 2015 | 105 | 2015 |
| Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice J Zhao, H Zhang, SB Liu, P Han, S Hu, Q Li, ZF Wang, QL Mao-Ying, ... Neuroscience 253, 172-182, 2013 | 62 | 2013 |
| Research progress on interleukin-33 and its roles in the central nervous system P Han, WL Mi, YQ Wang Neuroscience Bulletin 27 (5), 2011 | 51 | 2011 |
| Interleukin-33 mediates formalin-induced inflammatory pain in mice P Han, J Zhao, SB Liu, CJ Yang, YQ Wang, GC Wu, DM Xu, WL Mi Neuroscience 241, 59-66, 2013 | 40 | 2013 |
| Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells X Zhang, C Cheng, J Hou, X Qi, X Wang, P Han, X Yang Cellular & Molecular Immunology 16 (4), 392-400, 2019 | 35 | 2019 |
| Bcl-2 enhances chimeric antigen receptor T cell persistence by reducing activation-induced apoptosis H Wang, P Han, X Qi, F Li, M Li, L Fan, H Zhang, X Zhang, X Yang Cancers 13 (2), 197, 2021 | 34 | 2021 |
| Inhibition of spinal interlukin-33/ST2 signaling and downstream ERK and JNK pathways in electroacupuncture analgesia in formalin mice P Han, S Liu, M Zhang, J Zhao, Y Wang, G Wu, W Mi PloS one 10 (6), e0129576, 2015 | 33 | 2015 |
| 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells Q Dai, P Han, X Qi, F Li, M Li, L Fan, H Zhang, X Zhang, X Yang Frontiers in immunology 11, 539654, 2020 | 31 | 2020 |
| Genome-wide CRISPR screening identifies JAK1 deficiency as a mechanism of T-cell resistance P Han, Q Dai, L Fan, H Lin, X Zhang, F Li, X Yang Frontiers in immunology 10, 251, 2019 | 19 | 2019 |
| T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies F Li, H Zhang, W Wang, P Yang, Y Huang, J Zhang, Y Yan, Y Wang, ... Nature communications 13 (1), 4334, 2022 | 18 | 2022 |
| Pretreatment of mouse neural stem cells with carbon monoxide-releasing molecule-2 interferes with NF-κB p65 signaling and suppresses iron overload-induced apoptosis Z Xie, P Han, Z Cui, B Wang, Z Zhong, Y Sun, G Yang, Q Sun, L Bian Cellular and molecular neurobiology 36, 1343-1351, 2016 | 15 | 2016 |
| USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis M Li, Y Xu, J Liang, H Lin, X Qi, F Li, P Han, Y Gao, X Yang Molecular Therapy 29 (6), 2108-2120, 2021 | 14 | 2021 |
| Type I interferon promotes antitumor T cell response in CRPC by regulating MDSC L Fan, G Xu, J Cao, M Li, H Zhang, F Li, X Qi, X Zhang, Z Li, P Han, ... Cancers 13 (21), 5574, 2021 | 7 | 2021 |
| Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection X Zhang, P Han, H Wang, Y Xu, F Li, M Li, L Fan, H Zhang, Q Dai, H Lin, ... Molecular Therapy Methods & Clinical Development 21, 754-764, 2021 | 6 | 2021 |
| A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo F Li, W Xu, X Zhang, W Wang, S Su, P Han, H Wang, Y Xu, M Li, L Fan, ... Communications Biology 6 (1), 592, 2023 | 4 | 2023 |
| Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis. Cancers 2021, 13, 197 H Wang, P Han, X Qi, F Li, M Li, L Fan, H Zhang, X Zhang, X Yang s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2021 | 1 | 2021 |
| A highly degradable Mg-Al-Ca alloy with superior anti-tumor efficacy LW Qiwen Chen a c 1, Yunhao Fan b 1, Shu Dong a c, Ping Han d, Tian Xie b ... Journal of Magnesium and Alloys, 2023 | | 2023 |
| 分泌anti-PD-L1及IFNα的间充质干细胞联合治疗小鼠黑色素瘤 杨选明林浩，李民，韩萍， 中国免疫学杂志 38 (1), 12-17, 2022 | | 2022 |
| Engineering mesenchymal stem cells with neutralizing and anti-inflammation dual-capability against SARS-CoV-2 infection X Zhang, P Han, H Wang, Y Xu, F Li, M Li, L Fan, H Zhang, Q Dai, H Lin, ... | | 2020 |
